Mary Kathryn McKenna

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2025
Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b.

Stacey Van Pelt, Mark White, Candise Tat

|Aug 01, 2025
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas.

Harrison R Berger, Malina Maharana, Jeneffer Mirabal

|Jan 18, 2023
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.

Mary K McKenna, Ada Ozcan, Daniel Brenner

|Mar 08, 2022
Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.

James P Collard, Mary K McKenna, Sunil K Noothi

|Mar 12, 2020
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives.

Mary K McKenna, Amanda Rosewell-Shaw, Masataka Suzuki

|May 02, 2018
Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.

Sara S Alhakeem, Mary K McKenna, Karine Z Oben

Pageof 2